RVPH icon

Reviva Pharmaceuticals

21 hedge funds and large institutions have $34.4M invested in Reviva Pharmaceuticals in 2019 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 3 increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
21
Holders Change
+8
Holders Change %
+61.54%
% of All Funds
0.46%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
10
Increased
3
Reduced
Closed
1
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
MSU
1
Mizuho Securities USA
New York
$4.49M +$1.34M +132,608 +42%
OAM
2
Oxford Asset Management
United Kingdom
$3.74M
KIM
3
Karpus Investment Management
New York
$3.58M +$3.58M +354,025 New
WAM
4
Weiss Asset Management
Massachusetts
$3.34M +$1.28M +126,900 +62%
Bank of Montreal
5
Bank of Montreal
Ontario, Canada
$3.24M +$3.24M +322,000 New
PC
6
Periscope Capital
Ontario, Canada
$2.43M
SCM
7
Shaolin Capital Management
Florida
$2.43M +$2.43M +241,500 New
GCIA
8
Gabelli & Co Investment Advisers
New York
$1.96M +$1.96M +194,500 New
Walleye Trading
9
Walleye Trading
New York
$1.89M +$1.89M +187,181 New
Goldman Sachs
10
Goldman Sachs
New York
$1.51M
GF
11
Gabelli Funds
New York
$1.19M +$1.19M +118,200 New
PAM
12
Panagora Asset Management
Massachusetts
$1.17M
KPF
13
K2 Principal Fund
Ontario, Canada
$755K +$755K +75,000 New
HIM
14
HGC Investment Management
Ontario, Canada
$670K
BI
15
Bulldog Investors
New Jersey
$547K
BCM
16
Basso Capital Management
Connecticut
$507K
PAMP
17
Polar Asset Management Partners
Ontario, Canada
$504K
CI
18
Cowen Inc
New York
$342K +$89.5K +8,900 +35%
Royal Bank of Canada
19
Royal Bank of Canada
Ontario, Canada
$90K +$90K +8,900 New
UBS Group
20
UBS Group
Switzerland
$11K +$11K +1,100 New
GCL
21
Glazer Capital LLC
New York
-$491K -50,000 Closed